From: Ensuring HIV care to undocumented migrants in Israel: a public-private partnership case study
 | Initial Attempts (2001–2011) | Preparation (2012–2013) | Implementation (2014–2015) | Government Program (2016-Present) |
---|---|---|---|---|
Government Offices | DTA | DTA MoH General Director | DTA MoH General Director Pharmaceutical Division | DTA |
Non-Governmental Organizations | IATF | IATF; PHRI; Israeli HIV Medical Society | IATF; PHRI; Israeli HIV Medical Society | IATF |
International Organizations | TGF (refused) | UNHCR (refused) | Â | Â |
Health Services | Â | Â | TB, STI, and HIV Clinics Clalit Medical Organization Hadassah Medical Center | Â |
Private Companies | Â | Â | Pharmaceutical Companies/Suppliers Tel Aviv Pharmacy | Â |
Summary | Succeeded in extending care to pregnant women without health insurance. TGF concluded it wasn’t possible to provide ART at a discounted rate for migrants from countries that receive discounts | A change in leadership at the MoH created inter-office interests in extending HIV care. Partnerships in multiple sectors were developed. UNHCR concluded in wasn’t possible to negotiate discounted prices for ART. | Partners from multiple sectors came together to insure the feasibility of extending HIV care to undocumented migrants. Bi-annual meetings were held to insure clear communication between stakeholders | The program was fully absorbed as a government program. Services provided to undocumented migrants are now part of standard practice. |